Search results

1 – 10 of 11

View access options

Expert briefing

Publication date: 16 September 2022

Turkish health system’s troubles will stay a hot topic

Location:: TURKEY

Government parties recently blocked opposition moves to hold a parliamentary debate on attacks on health workers. The government is proud of its heath policies, but the system is…

HTML

Details

DOI: 10.1108/OXAN-DB272752

ISSN: 2633-304X

Keywords

Geographic

Turkey

ME/NAF

Topical

economy

industry

politics

social

fiscal

government

health

party

public sector

crime

legislation

opposition

pharmaceutical

private sector

reform

religion

wages

View access options

Expert briefing

Publication date: 2 July 2021

Bolsonaro woes will raise election doubts in Brazil

Location:: BRAZIL

This would require rebuilding bridges with some moderate figures, in order to gain support among the 57 million voters who rejected his party in 2018. However, it also requires a…

HTML

Details

DOI: 10.1108/OXAN-DB262518

ISSN: 2633-304X

Keywords

Geographic

Brazil

LA/C

Topical

economy

industry

politics

social

corruption

election

fiscal

government

health

legislation

opposition

party

pharmaceutical

policy

welfare

View access options

Expert briefing

Publication date: 17 August 2016

Puerto Rico's policy hurdles will depend on Washington

Location:: PUERTO RICO

Post-default politics in Puerto Rico.

HTML

Details

DOI: 10.1108/OXAN-DB213057

ISSN: 2633-304X

Keywords

Geographic

Puerto Rico

LA/C

United States

Topical

economy

politics

social

election

fiscal

government

growth

health

immigration

judicial

legislation

nationality

opposition

party

pensions

policy

population

poverty

referendum

reform

regional

regulation

welfare

industry

pharmaceutical

View access options

Expert briefing

Publication date: 5 November 2021

Prospects for India in 2022

Location:: PROSPECTS 2022

Meanwhile, GDP is projected by the Reserve Bank of India (RBI) to grow by 9.5% in the fiscal year ending March, rebounding from its 7.3% contraction in 2020/21. Economic goals…

HTML

Details

DOI: 10.1108/OXAN-DB265259

ISSN: 2633-304X

Keywords

Geographic

India

Afghanistan

Australia

China

Israel

Japan

Pakistan

United Arab Emirates

United Kingdom

United Nations

United States

PROSPECTS 2022

Topical

economy

international relations

politics

election

fiscal

foreign trade

government

growth

monetary

opposition

party

regulation

banking

border conflict

food

foreign policy

health

pharmaceutical

policy

prices

religion

agriculture

climate

debt

energy

labour

legislation

military

oil

privatisation

protest

reform

terrorism

View access options

Expert briefing

Publication date: 16 March 2016

New Zealand TPP approval is likely despite opposition

Location:: NEW ZEALAND

New Zealand's main political parties are divided on TPP ratification, which marks the first such division on a trade agreement in 40 years. The main opposition Labour party has…

HTML

Details

DOI: 10.1108/OXAN-DB210004

ISSN: 2633-304X

Keywords

Geographic

New Zealand

Australia

China

United States

Topical

economy

industry

international relations

politics

computers

consumer

electronics

employment

ethnic

food

foreign investment

foreign policy

foreign trade

integration

international law

labour

legislation

manufacturing

opposition

party

patents

pharmaceutical

policy

prices

property

protest

regulation

services

soft commodities

talks

technology

treaty

View access options

Expert briefing

Publication date: 3 October 2018

New NAFTA helps Canada’s Trudeau hurdle some problems

Location:: CANADA

Along with Mexico’s leader President Enrique Pena Nieto, whose term ends on December 1, the new US-Mexico-Canada Agreement (USMCA) will be signed by US President Donald Trump and…

HTML

Details

DOI: 10.1108/OXAN-DB238918

ISSN: 2633-304X

Keywords

Geographic

Canada

NAFTA

United States

Mexico

Topical

international relations

agriculture

automobile

consumer

food

foreign investment

foreign policy

foreign trade

judicial

legislation

manufacturing

pharmaceutical

economy

industry

election

opposition

party

View access options

Executive summary

Publication date: 23 September 2015

US government will not lower drug costs

Location:: UNITED STATES

UNITED STATES: Government will not lower drug costs

HTML

Details

DOI: 10.1108/OXAN-ES205523

ISSN: 2633-304X

Keywords

Geographic

United States

Canada

Topical

economy

industry

politics

government

legislation

opposition

party

pharmaceutical

regulation

View access options

Expert briefing

Publication date: 30 December 2020

Rise in Polish health spending could be more ambitious

Location:: POLAND

This has resulted in the limited availability of a range of health services and in structural problems, including insufficient human resources and public hospital debts. However…

HTML

Details

DOI: 10.1108/OXAN-DB258441

ISSN: 2633-304X

Keywords

Geographic

Poland

EUR

Topical

economy

politics

social

fiscal

government

health

industry

party

reform

emergency

legislation

opposition

pharmaceutical

View access options

Expert briefing

Publication date: 23 November 2021

Prospects for Pakistan in 2022

Location:: PROSPECTS 2022

Separately, the recent Taliban takeover of Afghanistan was a strategic win, given the military-security establishment’s long-standing support for the group. The Taliban’s 'Haqqani…

HTML

Details

DOI: 10.1108/OXAN-DB265641

ISSN: 2633-304X

Keywords

Geographic

Pakistan

Afghanistan

China

IMF-World Bank

India

Iran

Russia

Saudi Arabia

United States

PROSPECTS 2022

Topical

economy

international relations

politics

social

banking

border conflict

finance

foreign policy

government

growth

military

monetary

opposition

party

policy

prices

protest

religion

security

talks

terrorism

espionage

health

infrastructure

investment

legislation

oil

pharmaceutical

View access options

Expert briefing

Publication date: 9 September 2021

Thailand’s Prayut will push through obstacles

Location:: THAILAND

Prayut had the second-fewest votes cast for him and the most against him. The opposition probably did not expect to succeed with its censure motion, given the government’s…

HTML

Details

DOI: 10.1108/OXAN-DB263999

ISSN: 2633-304X

Keywords

Geographic

Thailand

APEC

China

Myanmar

United States

Topical

economy

international relations

politics

social

constitution

election

foreign policy

government

growth

health

opposition

party

pharmaceutical

reform

legislation

military

railway

summit

talks

tourism

transport

Access

Year

All dates (11)

Content type

Refine By Country

{"A":[{"count":"2","title":"Afghanistan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Afghanistan%22"},{"count":"2","title":"Australia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Australia%22"}],"B":[{"count":"1","title":"Brazil","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Brazil%22"}],"C":[{"count":"3","title":"Canada","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Canada%22"},{"count":"1","title":"Chile","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Chile%22"},{"count":"5","title":"China","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22China%22"}],"I":[{"count":"2","title":"India","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22India%22"},{"count":"1","title":"Iran","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Iran%22"},{"count":"1","title":"Israel","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Israel%22"}],"J":[{"count":"2","title":"Japan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Japan%22"}],"M":[{"count":"2","title":"Mexico","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Mexico%22"},{"count":"1","title":"Myanmar","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Myanmar%22"}],"N":[{"count":"1","title":"New Zealand","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22New+Zealand%22"}],"P":[{"count":"2","title":"Pakistan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Pakistan%22"},{"count":"1","title":"Peru","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Peru%22"},{"count":"1","title":"Poland","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Poland%22"},{"count":"1","title":"Puerto Rico","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Puerto+Rico%22"}],"R":[{"count":"1","title":"Russia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Russia%22"}],"S":[{"count":"1","title":"Saudi Arabia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Saudi+Arabia%22"}],"T":[{"count":"1","title":"Thailand","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Thailand%22"},{"count":"1","title":"Turkey","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22Turkey%22"}],"U":[{"count":"1","title":"United Arab Emirates","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22United+Arab+Emirates%22"},{"count":"1","title":"United Kingdom","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22United+Kingdom%22"},{"count":"1","title":"United Nations","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22United+Nations%22"},{"count":"8","title":"United States","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22economy%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-topical%3A%22opposition%22+AND+keyword-country%3A%22United+States%22"}]}

1 – 10 of 11

Details

DOI: 10.1108/OXAN-DB272752

ISSN: 2633-304X

Keywords

Geographic

Topical

Details

DOI: 10.1108/OXAN-DB262518

ISSN: 2633-304X

Keywords

Geographic

Topical

Details

DOI: 10.1108/OXAN-DB213057

ISSN: 2633-304X

Keywords

Geographic

Topical

Details

DOI: 10.1108/OXAN-DB265259

ISSN: 2633-304X

Keywords

Geographic

Topical

Details

DOI: 10.1108/OXAN-DB210004

ISSN: 2633-304X

Keywords

Geographic

Topical

Details

DOI: 10.1108/OXAN-DB238918

ISSN: 2633-304X

Keywords

Geographic

Topical

Details

DOI: 10.1108/OXAN-ES205523

ISSN: 2633-304X

Keywords

Geographic

Topical

Details

DOI: 10.1108/OXAN-DB258441

ISSN: 2633-304X

Keywords

Geographic

Topical

Details

DOI: 10.1108/OXAN-DB265641

ISSN: 2633-304X

Keywords

Geographic

Topical

Details

DOI: 10.1108/OXAN-DB263999

ISSN: 2633-304X

Keywords

Geographic

Topical

Access

Year

Content type

Refine By Country

We’re listening — tell us what you think

Something didn’t work…

All feedback is valuable

Join us on our journey

Platform update page

Questions & More Information